FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis Immunology
Research from Harvard University, Joslin Diabetes Center provides new data about arthritis immunology
March 15th, 2007
Scientists discuss in "Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis" new findings in arthritis. According to a study from the United States, "Regulatory T cells play a suppressive role in many autoimmune diseases and can potentially affect various steps in the progression of disease. The purpose of this study was to analyze the role of Treg cells in the control of arthritis development." "Using crosses and cell transfers, we tested the effect of the scurfy loss-of-function mutation of the Foxp3 gene in the K/BxN mouse model. In this model, arthritis develops as the result of the production of high levels of pathogenic...
Source: FDA Law Weekly (2007-03-15)
|
